Abstract:BackgroundAdverse Drug Reactions (ADRs) are of great public health concern. FDA-approved drug labeling summarizes ADRs of a drug product mainly in three sections, i.e., Boxed Warning (BW), Warnings and Precautions (WP), and Adverse Reactions (AR), where the severity of ADRs are intended to decrease in the order of BW>WP>AR. Several reported studies have extracted ADRs from labeling documents, but most, if not all, did not discriminate the severity of the ADRs by the different labeling sections. Such a practice could overstate or underestimate the impact of certain ADRs to the public health. In this study, we applied the Medical Dictionary for Regulatory Activities (MedDRA) to drug labeling and systematically analyzed and compared the ADRs from the three labeling sections with a specific emphasis on analyzing serious ADRs presented in BW, which is of most drug safety concern.ResultsThis study investigated New Drug Application (NDA) labeling documents for 1164 single-ingredient drugs using Oracle Text search to extract MedDRA terms. We found that only a small portion of MedDRA Preferred Terms (PTs), 3819 out of 21,920 or 17.42%, were observed in a whole set of documents. In detail, 466/3819 (12.0%) PTs were in BW, 2023/3819 (53.0%) were in WP, and 2961/3819 (77.5%) were in AR sections. We also found a higher overlap of top 20 occurring BW PTs with WP sections compared to AR sections. Within the MedDRA System Organ Class levels, serious ADRs (sADRs) from BW were prevalent in Nervous System disorders and Vascular disorders. A Hierarchical Cluster Analysis (HCA) revealed that drugs within the same therapeutic category shared the same ADR patterns in BW (e.g., nervous system drug class is highly associated with drug abuse terms such as dependence, substance abuse, and respiratory depression).ConclusionsThis study demonstrated that combining MedDRA standard terminologies with data mining techniques facilitated computer-aided ADR analysis of drug labeling. We also highlighted the importance of labeling sections that differ in seriousness and application in drug safety. Using sADRs primarily related to BW sections, we illustrated a prototype approach for computer-aided ADR monitoring and studies which can be applied to other public health documents.

Detecting adverse drug reactions for the drug Simvastatin

Detect adverse drug reactions for drug Alendronate

Detect adverse drug reactions for the drug Pravastatin

Detect Adverse Drug Reactions for Drug Aspirin

Detect adverse drug reactions for drug Atorvastatin

Feature selection in detection of adverse drug reactions from the Health Improvement Network (THIN) database

Detect adverse drug reactions for drug Pioglitazone

Identification of Adverse Drug Events in Chinese Clinical Narrative Text

Study of Serious Adverse Drug Reactions Using FDA-approved Drug Labeling and MedDRA

Predicting Drugs Suspected of Causing Adverse Drug Reactions Using Graph Features and Attention Mechanisms

A Survey on Computational Approaches to Predicting Adverse Drug Reactions.

BiMPADR: A Deep Learning Framework for Predicting Adverse Drug Reactions in New Drugs

Drug Safety Signal Detection in a Regional Healthcare Database Using the Tree-Based Scan Statistic and Comparison to 3 Other Mining Methods

Developing A Deep Learning Natural Language Processing Algorithm For Automated Reporting Of Adverse Drug Reactions

Detecting Pharmacovigilance Signals Combining Electronic Medical Records With Spontaneous Reports: A Case Study of Conventional Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis

Systematic Drug Safety Evaluation Based on Public Genomic Expression (connectivity Map) Data: Myocardial and Infectious Adverse Reactions As Application Cases.

Interactive crowdsourcing to spontaneous reporting of Adverse Drug Reactions

Mining Real-World Big Data to Characterize Adverse Drug Reaction Quantitatively: Mixed Methods Study

Detecting high-quality signals of adverse drug-drug interactions from spontaneous reporting data

Application of Data Mining Algorithm to Detect Adverse Drug Reaction Signal

A method for systematic discovery of adverse drug events from clinical notes.